FRESENIUS MEDICAL CARE AG: 20-F filed 2010-02-24
What FRESENIUS MEDICAL CARE AG reported in its annual report (foreign private issuer) filed 2010-02-24 (fiscal FY 2009): 38 published measures, 97 facts as tagged in accession 0000950123-10-016350.
This filing
- Form
- 20-F (annual report (foreign private issuer))
- Filed
- 2010-02-24
- Fiscal period
- fiscal FY 2009
- Accession
- 0000950123-10-016350 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All FRESENIUS MEDICAL CARE AG filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 15,821,315,000 | USD | |
| At 2008-12-31 | 14,919,676,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 8,791,622,000 | USD | |
| At 2008-12-31 | 8,796,890,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 6,820,932,000 | USD | |
| At 2008-12-31 | 5,962,282,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 301,225,000 | USD | |
| At 2008-12-31 | 221,584,000 | USD | |
| At 2007-12-31 | 244,690,000 | USD | |
| At 2006-12-31 | 159,010,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 891,138,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 817,607,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 717,130,000 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 1,338,617,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 1,016,398,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 1,199,574,000 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 573,606,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 687,356,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 572,721,000 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | -558,127,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -156,058,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | -340,668,000 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | -698,024,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -891,401,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | -776,953,000 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 3,111,530,000 | USD | |
| At 2008-12-31 | 2,452,332,000 | USD |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 2.99 | USD/shares | 365 |
| 2008-01-01 to 2008-12-31 | 2.75 | USD/shares | 366 |
| 2007-01-01 to 2007-12-31 | 2.43 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 2.99 | USD/shares | 365 |
| 2008-01-01 to 2008-12-31 | 2.74 | USD/shares | 366 |
| 2007-01-01 to 2007-12-31 | 2.42 | USD/shares | 365 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 490,413,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 475,702,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 453,765,000 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 2,419,570,000 | USD | |
| At 2008-12-31 | 2,236,078,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 1,755,596,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 1,672,432,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 1,580,122,000 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 4,727,800,000 | USD | |
| At 2008-12-31 | 4,211,997,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 321,360,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 361,553,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 399,635,000 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 2,609,715,000 | USD | |
| At 2008-12-31 | 3,144,412,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 362,407,000 | USD | |
| At 2008-12-31 | 366,017,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 7,511,434,000 | USD | |
| At 2008-12-31 | 7,309,910,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 2,285,909,000 | USD | |
| At 2008-12-31 | 2,176,316,000 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 821,654,000 | USD | |
| At 2008-12-31 | 707,050,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 3,831,512,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 3,628,848,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 3,355,795,000 | USD | 365 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 7,415,965,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 6,983,475,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 6,364,519,000 | USD | 365 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 1,982,106,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 1,876,177,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 1,709,150,000 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 93,810,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 80,239,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 66,523,000 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 295,746,635 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 3,389,111,000 | USD | |
| At 2008-12-31 | 3,293,918,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | -49,724,000 | USD | |
| At 2008-12-31 | -151,284,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 7,029,693,000 | USD | |
| At 2008-12-31 | 6,122,786,000 | USD | |
| At 2007-12-31 | 5,681,031,000 | USD | |
| At 2006-12-31 | 4,945,320,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 859,195,000 | USD | |
| At 2008-12-31 | 846,496,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 238,567,000 | USD | |
| At 2008-12-31 | 222,390,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 307,112,000 | USD | |
| At 2008-12-31 | 319,602,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2009-12-31 | 1,335,553,000 | USD | |
| At 2008-12-31 | 1,288,433,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 965,220,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 859,988,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 755,310,000 | USD | 365 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 992,698,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 565,445,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 823,424,000 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 457,085,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 415,671,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 363,330,000 | USD | 365 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-01-01 to 2009-12-31 | 88,933,000 | USD | 365 |
| 2008-01-01 to 2008-12-31 | 94,112,000 | USD | 366 |
| 2007-01-01 to 2007-12-31 | 72,825,000 | USD | 365 |
Inspect the source
- Entity
- FRESENIUS MEDICAL CARE AG / CIK 0001333141
- Captured
- 2026-09-19T11:17:38.075Z
- SEC response SHA-256
e87bd4359ff04ac590c7c6db67d662bf0b7bf6cf5d3d8e5bcf17a7c91b1e4c28
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001333141.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))